| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |